Sunder Biomedical Tech Co (4115.TWO) Stock Price
Sunder Biomedical Tech Co Price
Over the last 24 years Sunder Biomedical Tech Co grew revenue by 7.4% annually, reaching 753.45 M TWD. Earnings per share have grown at 15.9% per year over the last 23 years. For Sunder Biomedical Tech Co, the net margin of -2.2% is down versus 6.2% a few years ago. At today's price the dividend yield works out to roughly 4.05%.
Sunder Biomedical Tech Co stock price
Sunder Biomedical Tech Co business model & stock analysis
Frequently asked questions about Sunder Biomedical Tech Co
Converted at the current exchange rate, the Sunder Biomedical Tech Co share trades at 0.21 EUR (7.41 TWD).
The revenue cannot currently be calculated for Sunder Biomedical Tech Co.
The profit cannot currently be calculated for Sunder Biomedical Tech Co.
The P/E ratio cannot be calculated for Sunder Biomedical Tech Co at the moment.
The P/S cannot be calculated for Sunder Biomedical Tech Co currently.
The Eulerpool Quality Score for Sunder Biomedical Tech Co is 2/10.
The ISIN of Sunder Biomedical Tech Co is TW0004115001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sunder Biomedical Tech Co is 4115.TWO. The ticker symbol is used to trade Sunder Biomedical Tech Co shares on the stock exchange.
Sunder Biomedical Tech Co stock
Sunder Biomedical Tech Co Peer Group
Sunder Biomedical Tech Co FIGI
All fundamentals and in-depth analysis of Sunder Biomedical Tech Co
Our stock analysis for Sunder Biomedical Tech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sunder Biomedical Tech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.